Genome&Company joins global pharma Lilly's TuneLab; accelerating AI drug development
Predicted impact: Low
Lilly TuneLab participation already reported several times; no financial terms given
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.